Cowealth Medical China Statistics
Total Valuation
SHA:603122 has a market cap or net worth of CNY 3.41 billion. The enterprise value is 3.31 billion.
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603122 has 398.05 million shares outstanding. The number of shares has increased by 2.87% in one year.
| Current Share Class | 398.05M |
| Shares Outstanding | 398.05M |
| Shares Change (YoY) | +2.87% |
| Shares Change (QoQ) | +31.57% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 1.67% |
| Float | 172.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.33 |
| PB Ratio | 3.28 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.84 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.80 |
Financial Efficiency
Return on equity (ROE) is -2.49% and return on invested capital (ROIC) is -3.48%.
| Return on Equity (ROE) | -2.49% |
| Return on Assets (ROA) | -1.37% |
| Return on Invested Capital (ROIC) | -3.48% |
| Return on Capital Employed (ROCE) | -3.12% |
| Weighted Average Cost of Capital (WACC) | 4.13% |
| Revenue Per Employee | 3.98M |
| Profits Per Employee | -167,061 |
| Employee Count | 161 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.00 |
Taxes
| Income Tax | -5.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.99% in the last 52 weeks. The beta is -0.02, so SHA:603122's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -63.99% |
| 50-Day Moving Average | 12.08 |
| 200-Day Moving Average | 13.67 |
| Relative Strength Index (RSI) | 29.08 |
| Average Volume (20 Days) | 24,006,172 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603122 had revenue of CNY 640.00 million and -26.90 million in losses. Loss per share was -0.06.
| Revenue | 640.00M |
| Gross Profit | 103.02M |
| Operating Income | -32.55M |
| Pretax Income | -31.90M |
| Net Income | -26.90M |
| EBITDA | -24.76M |
| EBIT | -32.55M |
| Loss Per Share | -0.06 |
Full Income Statement Balance Sheet
The company has 140.34 million in cash and 35.59 million in debt, with a net cash position of 104.75 million or 0.26 per share.
| Cash & Cash Equivalents | 140.34M |
| Total Debt | 35.59M |
| Net Cash | 104.75M |
| Net Cash Per Share | 0.26 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 2.61 |
| Working Capital | 731.43M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -67.94 million and capital expenditures -11.66 million, giving a free cash flow of -79.60 million.
| Operating Cash Flow | -67.94M |
| Capital Expenditures | -11.66M |
| Depreciation & Amortization | 7.78M |
| Net Borrowing | 12.45M |
| Free Cash Flow | -79.60M |
| FCF Per Share | -0.20 |
Full Cash Flow Statement Margins
Gross margin is 16.10%, with operating and profit margins of -5.09% and -4.20%.
| Gross Margin | 16.10% |
| Operating Margin | -5.09% |
| Pretax Margin | -4.98% |
| Profit Margin | -4.20% |
| EBITDA Margin | -3.87% |
| EBIT Margin | -5.09% |
| FCF Margin | n/a |
Dividends & Yields
SHA:603122 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.87% |
| Shareholder Yield | -2.87% |
| Earnings Yield | -0.75% |
| FCF Yield | -2.33% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603122 has an Altman Z-Score of 10.36 and a Piotroski F-Score of 2.
| Altman Z-Score | 10.36 |
| Piotroski F-Score | 2 |